AI assistant
Sending…
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Director's Dealing 2021
Apr 16, 2021
30798_dirs_2021-04-16_2e2494fd-d5a6-4ef6-8c78-c4dba6885266.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK: 0001100682
Period of Report: 2021-04-15
Reporting Person: Smith David Ross (Corporate Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-15 | Common Stock | S | 2000 | $320.00 | Disposed | 14862 | Direct |
Footnotes
F1: This sale occurred pursuant to a 10b5-1 Trading Plan.
More from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
May 11
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Regulatory Filings
2026
Feb 25
Board/Management Information
2026
Feb 18
Annual Report
2026
Feb 18
Earnings Release
2026
Feb 18
Major Shareholding Notification
2026
Feb 10